News Sentiment

IMMP sentiment intelligence

Immutep Ltd ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.41 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-2.2% over one week, +9.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Immutep's Eftilagimod Alfa Quality of Life Findings Approved for ESMO Congress 2026 in Madrid

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -2.2% Price reacting lower
Trend fit Trend inactive 9.5% over four weeks
Fair value -78.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 33
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 10
Market source 7
GlobeNewswire 6
Stock Titan 4
DirectorsTalk Interviews 4
Moomoo 3
Investing.com 3
Kalkine 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 16
Regulatory and legal 6
Analyst action 4

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
TradingView Direct company coverage

Immutep Ltd Actuals & Estimates (FWB:YP1B)

This article provides financial actuals and estimates for Immutep Ltd (FWB: YP1B), an Australian biotechnology company. It details analyst forecasts, historical stock prices, recent earnings and revenue, and confirms that the company does not pay dividends. The report also highli

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 12:39
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Immutep Ltd – FWB:YP1B

This page displays the "Price to sales forward" metric for Immutep Ltd (FWB:YP1B) on the Frankfurt Stock Exchange. The specific value, change, and percentage change for this metric are presented, though the actual numerical data is not visible in the provided content. The page al

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 11:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Immutep Ltd – FWB:YP1B

The article discusses the enterprise value to EBITDA forward for Immutep Ltd (FWB:YP1B) on the Frankfurt Stock Exchange. It provides financial context for the company's valuation metrics.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 05:10
Source
TradingView